At present, there are more kinds of Chinese patent medicines for the treatment of diabetes, and the more representative ones include Zinlida granules and Tianqi hypoglycemic capsules, which can benefit qi and nourish yin to improve insulin resistance, and achieve the purpose of generating fluid and quenching thirst by regulating the spleen, so as to restore part of the pancreatic β-cell function, which can be the first choice for patients with initial onset of diabetes, early diabetes or elderly diabetes, and for patients who have already applied oral hypoglycemic drugs, or It can also be used as an adjunctive treatment for patients who are already taking oral hypoglycemic drugs or insulin. In addition to the above two kinds of Chinese patent medicines, it also includes Yuquan San and Ginseng and Astragalus granules. The specific medication should be combined with clinical practice and guided by a doctor’s interview.